Estrogen Receptor-Alpha, Breast Cancer Patients And Tamoxifen Response
Researchers have found evidence of a statistically significant survival benefit from adjuvant tamoxifen among patients whose estrogen receptor (ER)-positive tumors had high levels of phosphorylation of ER-alpha; at serine-118 (ER-alpha S118-P), according to a brief communication published online November 25 in the Journal of the National Cancer Institute. Approximately 50% of breast carcinomas are resistant to tamoxifen.
source : www.medicalnewstoday.com
Home Income Profit System
You can make money working from the comfort of your own home!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
CreditReport.com
Get your credit report and score in just seconds!
Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
You can make money working from the comfort of your own home!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
CreditReport.com
Get your credit report and score in just seconds!
Gevalia Stainless Steel Bundle
Save 75% on this Coffee Bundle When You Try Gevalia!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Related News:
- Gaps Remain in Cancer Palliative Care
- Testicular Cancer Treatments Worse than the Disease
- Charlotte Gerson talks out about the cancer industry and natural cancer remedies
- Discovery Of Opposing Functions Of A Key Molecule In The Development Of Organisms Could Benefit Cancer Research
- SGO: Drug Combination Slows Recurrent Ovarian Cancer
- Researchers Develop Tool To Help Study Prostate Cancer
- Home Specimen Collection Boosts Cervical Cancer Screening
- Vitamin D slashes risk of bowel cancer by 40 percent
- Reovirus may be a novel approach to prostate cancer treatment
- MHNCS: PET May Predict Cancer Aggression (CME/CE)
Details :
Submited at Friday, November 27th, 2009 at 7:00 am on Endocrinology by admin
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...
















